London, June 15, 2026, 14:08 BST
- Beazley was quoted at 1,283p, unchanged on the day, leaving the stock just below Zurich’s remaining 1,310p cash consideration.
- The latest catalyst is regulatory: Zurich has notified the European Commission of its plan to buy Beazley.
- The shares look more like a deal-arbitrage trade than a normal valuation call: upside is limited if the deal completes, but delay or clearance risk still matters.
Beazley Plc shares were steady in London trading on Monday, holding near the Zurich Insurance takeover price as investors shifted their attention from shareholder approval to regulatory timing. The stock was quoted at 1,283p at 14:05 BST on Google Finance, unchanged on the session, while Hargreaves Lansdown showed a 1,283p sell price and 1,283.5p buy price with the FTSE 100 slightly higher.
The immediate news is not Beazley’s underwriting performance, but the takeover timetable. Insurance Business reported that Zurich formally notified the European Commission on June 11, starting a Phase I review — the first stage of an EU competition assessment — for its planned acquisition of the London-listed specialty insurer. The European Commission’s own merger update page lists ZURICH / BEAZLEY as an ongoing simplified case.
That matters for the share price because Beazley is now trading mainly on deal risk. Zurich’s recommended cash offer gives Beazley holders 1,310p in cash plus a 25p permitted dividend, taking the headline value to 1,335p per share; the dividend had an ex-dividend date of March 19 and payment date of May 1, so the market is now focused largely on the 1,310p cash leg. At 1,283p, the stock sits about 2.1% below that remaining cash amount. In takeover situations, this gap is called the “spread”: it usually narrows when investors see completion as more certain or faster, and widens when they worry about regulatory delays, court approval or a deal break. Investegate
The bull case is straightforward. Beazley shareholders have already voted heavily in favour, with 99.91% of scheme shares voted backing the scheme at the Court Meeting and 99.92% of Beazley shares voted supporting the special resolution at the General Meeting. Zurich has said the combination would create a specialty insurance business with about US$15 billion of pro forma gross written premiums, and Zurich CEO Mario Greco said the deal would create “the world’s leading Specialty underwriter.” Investegate
The bear case is that the remaining upside is small while the process is not finished. The transaction still needs court sanction and regulatory clearances, including from the European Commission and other insurance regulators, and Beazley’s standalone numbers are not risk-free: 2025 profit before tax fell 19% to $1.15 billion, insurance written premiums slipped 1%, and the combined ratio was 81%. A combined ratio measures claims and expenses as a share of insurance revenue; below 100% means underwriting is profitable, but a rising ratio can still signal weaker margins. Chief Executive Adrian Cox said the company was operating “in a softening insurance rating environment,” which is one reason the takeover premium has carried so much weight for investors. Investegate
The next major catalyst is the regulatory path, especially the EU Phase I review and the later court hearing expected in the second half of 2026. If the deal remains pending into the summer, Beazley’s own calendar lists interim results for August 5, 2026, which would give investors a fresh look at underwriting trends. For now, the stock looks fairly valued but process-risky: attractive only for investors comfortable with a low-single-digit spread to the cash offer, less attractive for those seeking open-ended upside from Beazley as an independent insurer.
